Insider Transactions in Q1 2022 at Intuitive Surgical Inc (ISRG)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-84.71%
|
$578,000
$289.96 P/Share
|
|
Feb 28
2022
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,918
-19.3%
|
$556,220
$290.33 P/Share
|
|
Feb 28
2022
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,867
+28.01%
|
-
|
|
Feb 28
2022
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,119
-0.95%
|
$324,510
$290.33 P/Share
|
|
Feb 28
2022
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,256
+1.88%
|
-
|
|
Feb 28
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,119
-32.16%
|
$324,510
$290.33 P/Share
|
|
Feb 28
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,256
+39.33%
|
-
|
|
Feb 28
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
1,008
-13.69%
|
$292,320
$290.33 P/Share
|
|
Feb 28
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
2,175
+22.8%
|
-
|
|
Feb 28
2022
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
560
-3.01%
|
$162,400
$290.33 P/Share
|
|
Feb 28
2022
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,128
+5.71%
|
-
|
|
Feb 28
2022
|
Jamie Samath CFO and Head of Business Techn |
SELL
Payment of exercise price or tax liability
|
Direct |
539
-13.63%
|
$156,310
$290.33 P/Share
|
|
Feb 28
2022
|
Jamie Samath CFO and Head of Business Techn |
BUY
Exercise of conversion of derivative security
|
Direct |
1,257
+24.12%
|
-
|
|
Feb 28
2022
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
295
-9.9%
|
$85,550
$290.33 P/Share
|
|
Feb 28
2022
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
852
+22.23%
|
-
|
|
Feb 28
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
654
-3.67%
|
$189,660
$290.33 P/Share
|
|
Feb 28
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,449
+7.52%
|
-
|
|
Feb 28
2022
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,119
-19.8%
|
$324,510
$290.33 P/Share
|
|
Feb 28
2022
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
2,256
+28.53%
|
-
|
|
Feb 26
2022
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,503
-19.85%
|
$440,379
$293.51 P/Share
|
|
Feb 26
2022
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,030
+28.58%
|
-
|
|
Feb 26
2022
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
850
-0.73%
|
$249,050
$293.51 P/Share
|
|
Feb 26
2022
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+1.45%
|
-
|
|
Feb 26
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
850
-40.98%
|
$249,050
$293.51 P/Share
|
|
Feb 26
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+45.23%
|
-
|
|
Feb 26
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
737
-12.44%
|
$215,941
$293.51 P/Share
|
|
Feb 26
2022
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,590
+21.16%
|
-
|
|
Feb 26
2022
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
702
-3.86%
|
$205,686
$293.51 P/Share
|
|
Feb 26
2022
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,467
+7.46%
|
-
|
|
Feb 26
2022
|
Jamie Samath CFO and Head of Business Techn |
SELL
Payment of exercise price or tax liability
|
Direct |
445
-14.16%
|
$130,385
$293.51 P/Share
|
|
Feb 26
2022
|
Jamie Samath CFO and Head of Business Techn |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+29.01%
|
-
|
|
Feb 26
2022
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
211
-9.02%
|
$61,823
$293.51 P/Share
|
|
Feb 26
2022
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
609
+20.65%
|
-
|
|
Feb 26
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
580
-3.42%
|
$169,940
$293.51 P/Share
|
|
Feb 26
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+7.05%
|
-
|
|
Feb 26
2022
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
850
-20.02%
|
$249,050
$293.51 P/Share
|
|
Feb 26
2022
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+28.75%
|
-
|
|
Feb 16
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,478
-87.28%
|
$716,142
$289.0 P/Share
|
|
Feb 15
2022
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,271
-32.58%
|
$656,319
$289.31 P/Share
|
|
Feb 15
2022
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,749
+39.61%
|
-
|
|
Feb 15
2022
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
328
-9.4%
|
$94,792
$289.31 P/Share
|
|
Feb 15
2022
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
879
+19.99%
|
-
|
|
Feb 15
2022
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,455
-33.3%
|
$998,495
$289.31 P/Share
|
|
Feb 15
2022
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,998
+43.47%
|
-
|
|
Feb 15
2022
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,417
-27.46%
|
$409,513
$289.31 P/Share
|
|
Feb 15
2022
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
3,873
+42.23%
|
-
|
|
Feb 15
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
972
-3.11%
|
$280,908
$289.31 P/Share
|
|
Feb 15
2022
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
3,186
+9.23%
|
-
|
|
Feb 15
2022
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,160
-0.94%
|
$624,240
$289.31 P/Share
|
|
Feb 15
2022
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,373
+2.27%
|
-
|